IDBS and Alchemi partnered to accelerate AI-driven preparation of biopharma regulatory filings, linking AI agents to the IDBS Polar governed data backbone. The companies said the approach is intended to keep CMC documentation auditable and compliant by drafting documents directly from traceable, validated datasets.